Intermediate and premutation FMR1 alleles in women with occult primary ovarian insufficiency

Fertility and Sterility

Volumn 92, Issue 2, 2009, Pages 464-470

  Streuli, Isabelle ^a   Fraisse, Timothée ^a   Ibecheole, Victoria ^a   Moix, Isabelle ^a   Morris, Michael A ^a   de Ziegler, Dominique ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

FMR1 gene; Fragile X syndrome; intermediate allele; occult primary ovarian insufficiency; premature ovarian failure; premutation

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FEMALE INFERTILITY; FMR1 GENE; GENE; HUMAN; KARYOTYPE; MENTAL DEFICIENCY; OVARY FUNCTION; OVARY HYPERSTIMULATION; OVARY INSUFFICIENCY; PRIORITY JOURNAL; REPRODUCTION;

ADULT; ALLELES; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; OVARIAN FAILURE, PREMATURE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 67651083488     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.07.007     Document Type: Article

References (46)

1. Turner G., Webb T., Wake S., and Robinson H. Prevalence of fragile X syndrome. Am J Med Genet 64 (1996) 196-197
2. Verkerk A.J., Pieretti M., Sutcliffe J.S., Fu Y.H., Kuhl D.P., Pizzuti A., et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65 (1991) 905-914
3. American College of Obstetricians and Gynecologists Committee on Genetics. ACOG committee opinion. No. 338: Screening for fragile X syndrome. Obstet Gynecol 107 (2006) 1483-1485
4. Fu Y.H., Kuhl D.P., Pizzuti A., Pieretti M., Sutcliffe J.S., Richards S., et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67 (1991) 1047-1058
5. Terracciano A., Pomponi M.G., Marino G.M., Chiurazzi P., Rinaldi M.M., Dobosz M., et al. Expansion to full mutation of a FMR1 intermediate allele over two generations. Eur J Hum Genet 12 (2004) 333-336
6. Zuñiga A., Juan J., Mila M., and Guerrero A. Expansion of an intermediate allele of the FMR1 gene in only two generations. Clin Genet 68 (2005) 471-473
7. Nolin S.L., Brown W.T., Glicksman A., Houck Jr. G.E., Gargano A.D., Sullivan A., et al. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet 72 (2003) 454-464
8. Crawford D.C., Acuña J.M., and Sherman S.L. FMR1 and the fragile X syndrome: human genome epidemiology review. Genet Med 3 (2001) 359-371
9. Oberle I., Rousseau F., Heitz D., Kretz C., Devys D., Hanauer A., et al. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252 (1991) 1097-1102
10. Pieretti M., Zhang F.P., Fu Y.H., Warren S.T., Oostra B.A., Caskey C.T., et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66 (1991) 817-822
11. Wittenberger M.D., Hagerman R.J., Sherman S.L., McConkie-Rosell A., Welt C.K., Rebar R.W., et al. The FMR1 premutation and reproduction. Fertil Steril 87 (2007) 456-465
12. Allingham-Hawkins D.J., Babul-Hirji R., Chitayat D., Holden J.J., Yang K.T., Lee C., et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study-preliminary data. Am J Med Genet 83 (1999) 322-325
13. Sullivan A.K., Marcus M., Epstein M.P., Allen E.G., Anido A.E., Paquin J.J., et al. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 20 (2005) 402-412
14. Conway G.S., Payne N.N., Webb J., Murray A., and Jacobs P.A. Fragile X premutation screening in women with premature ovarian failure. Hum Reprod 13 (1998) 1184-1187
15. Murray A., Webb J., Grimley S., Conway G., and Jacobs P. Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet 35 (1998) 637-640
16. Gersak K., Meden-Vrtovec H., and Peterlin B. Fragile X premutation in women with sporadic premature ovarian failure in Slovenia. Hum Reprod 18 (2003) 1637-1640
17. Ennis S., Ward D., and Murray A. Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers. Eur J Hum Genet 14 (2006) 253-255
18. Braat D.D., Smits A.P., and Thomas C.M. Menstrual disorders and endocrine profiles in fragile X carriers prior to 40 years of age: a pilot study. Am J Med Genet 83 (1999) 327-328
19. Murray A., Ennis S., MacSwiney F., Webb J., and Morton N.E. Reproductive and menstrual history of females with fragile X expansions. Eur J Hum Genet 8 (2000) 247-252
20. Murray A., Webb J., MacSwiney F., Shipley E.L., Morton N.E., and Conway G.S. Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women. Hum Reprod 14 (1999) 1217-1218
21. Hundscheid R.D., Braat D.D., Kiemeney L.A., Smits A.P., and Thomas C.M. Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives. Hum Reprod 16 (2001) 457-462
22. Welt C.K., Smith P.C., and Taylor A.E. Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endocrinol Metab 89 (2004) 4569-4574
23. Allen E.G., Sullivan A.K., Marcus M., Small C., Dominguez C., Epstein M.P., et al. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod 22 (2007) 2142-2152
24. Rohr J., Allen E.G., Charen K., Giles J., He W., Dominguez C., et al. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study. Hum Reprod 23 (2008) 1220-1225
25. Kalantaridou S.N., Vanderhoof V.H., Calis K.A., Corrigan E.C., Troendle J.F., and Nelson L.M. Sexual function in young women with spontaneous 46,XX primary ovarian insufficiency. Fertil Steril (2007) Published online 27 October 2007 [Epub ahead of print]
26. Nelson L.M. FMR1 premutation and premature ovarian failure. Worldwide Community Guideline Development (2006). www.fmr1pof.com
27. Welt C.K. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol 68 (2008) 499-509
28. Beckers N.G., Macklon N.S., Eijkemans M.J., and Fauser B.C. Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian ageing. Fertil Steril 78 (2002) 291-297
29. Farhi J., Homburg R., Ferber A., Orvieto R., and Ben Rafael Z. Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure pre-empting the rise of basal follicle stimulating hormone levels. Hum Reprod 12 (1997) 241-243
30. Buckler H.M., Evans C.A., Mamtora H., Burger H.G., and Anderson D.C. Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles. J Clin Endocrinol Metab 72 (1991) 116-124
31. Cameron I.T., O'Shea F.C., Rolland J.M., Hughes E.G., de Kretser D.M., and Healy D.L. Occult ovarian failure: a syndrome of infertility, regular menses, and elevated follicle stimulating hormone concentrations. J Clin Endocrinol Metab 67 (1988) 1190-1194
32. Ahmed Ebbiary N.A., Lenton E.A., Salt C., Ward A.M., and Cooke I.D. The significance of elevated basal follicle stimulating hormone in regularly menstruating infertile women. Hum Reprod 9 (1994) 245-252
33. Healy D.L. Occult ovarian failure. Curr Ther Endocrinol Metab 5 (1994) 198-199
34. Coulam C.B., Adamson S.C., and Annegers J.F. Incidence of premature ovarian failure. Obstet Gynecol 67 (1986) 604-606
35. Nelson L.M., Covington S.N., and Rebar R.W. An update: spontaneous premature ovarian failure is not an early menopause. Fertil Steril 83 (2005) 1327-1332
36. Letur H., Martin-Pont B., Fénichel P., and GEDO. Spontaneous pregnancies and premature menopause. Gynecol Obstet Fertil 32 (2004) 748-755
37. Corrigan E.C., Raygada M.J., Vanderhoof V.H., and Nelson L.M. A woman with spontaneous premature ovarian failure gives birth to a child with fragile X syndrome. Fertil Steril 84 (2005) 1508
38. Bodega B., Bione S., Dalprà L., Toniolo D., Ornaghi F., Vegetti W., et al. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod 21 (2006) 952-957
39. Bretherick K.L., Fluker M.R., and Robinson W.P. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet 117 (2005) 376-382
40. Kenneson A., Zhang F., Hagedorn C.H., and Warren S.T. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet 10 (2001) 1449-1454
41. Loesch D.Z., Bui Q.M., Huggins R.M., Mitchell R.J., Hagerman R.J., and Tassone F. Transcript levels of the intermediate size or grey zone fragile X mental retardation 1 alleles are raised, and correlate with the number of CGG repeats. J Med Genet 44 (2007) 200-204
42. Greco C.M., Hagerman R.J., Tassone F., Chudley A.E., Del Bigio M.R., Jacquemont S., et al. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 125 (2002) 1760-1771
43. Tassone F., Iwahashi C., and Hagerman P.J. FMR1 RNA within the intranuclear inclusions of fragile X-associated tremor/ataxia syndrome (FXTAS). RNA Biol 1 (2004) 103-105
44. Sherman S., Pletcher B.A., and Driscoll D.A. Fragile X syndrome: diagnostic and carrier testing. Genet Med 7 (2005) 584-587
45. Akande V.A., Fleming C.F., Hunt L.P., Keay S.D., and Jenkins J.M. Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment. Hum Reprod 17 (2002) 2003-2008
46. Conway G.S., Hettiarachchi S., Murray A., and Jacobs P.A. Fragile X premutations in familial premature ovarian failure. Lancet 346 (1995) 309-310